Literature DB >> 21443399

Clozapine use in Australia.

Geethal Malalagama, Tarun Bastiampillai, Rohan Dhillon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21443399     DOI： 10.3109/10398562.2010.525646

Source DB:  PubMed          Journal:  Australas Psychiatry        ISSN： 1039-8562            Impact factor:   1.369


× No keyword cloud information.
  6 in total

1.  Pathway to clozapine use: a comparison between a patient cohort from New Zealand and a cohort from the United Kingdom.

Authors:  Amanda J Wheeler; Celia L Feetam; Jeff Harrison
Journal:  Clin Drug Investig       Date:  2014-03       Impact factor: 2.859

2.  Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.

Authors:  Samantha A Hollingworth; Karl Winckel; Nargess Saiepour; Amanda J Wheeler; Nicholas Myles; Dan Siskind
Journal:  Psychopharmacology (Berl)       Date:  2018-03-27       Impact factor: 4.530

Review 3.  Worldwide Differences in Regulations of Clozapine Use.

Authors:  Jimmi Nielsen; Corina Young; Petru Ifteni; Taishiro Kishimoto; Yu-Tao Xiang; Peter F J Schulte; Christoph U Correll; David Taylor
Journal:  CNS Drugs       Date:  2016-02       Impact factor: 5.749

4.  Consumer access to clozapine in Australia: how does this compare to New Zealand and the United Kingdom?

Authors:  Sally-Anne Knowles; Sara S Mcmillan; Amanda J Wheeler
Journal:  Pharm Pract (Granada)       Date:  2016-06-15

5.  Clozapine prescribing practice and trends in Qatar: First national observational study.

Authors:  Ovais Wadoo; Javed Latoo; Majid Alabdulla; Yassin Eltorki; Sadaf Riaz; Mustafa Abdul Karim; Mohammed Abu-Hafizah; Shuja Reagu
Journal:  Brain Behav       Date:  2022-06-01       Impact factor: 3.405

Review 6.  Clozapine: a review of clinical practice guidelines and prescribing trends.

Authors:  Stephanie Warnez; Silvia Alessi-Severini
Journal:  BMC Psychiatry       Date:  2014-04-07       Impact factor: 3.630
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.